What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
FDA Warning Letter to Kare Solutions LLC dba Zappy
The FDA issued a warning letter to Kare Solutions LLC dba Zappy for misbranding compounded drug products, including semaglutide, tirzepatide, and liraglutide. The agency found that Zappy's website made false or misleading claims about these products, suggesting they were FDA-approved or compounded by Zappy when they were not.
FDA Warning Letter to Strut Health, LLC
The FDA issued a warning letter to Strut Health, LLC on February 20, 2026, for misbranding compounded semaglutide and tirzepatide products. The company's website allegedly made false or misleading claims about these drugs, violating the Federal Food, Drug, and Cosmetic Act.
FDA Warning Letter to GenoGenix LLC
The FDA issued a warning letter to GenoGenix LLC for serious deficiencies in drug production practices, including failures to meet conditions for outsourcing facilities and insanitary conditions. The company has ceased production and initiated a voluntary recall of drug products.
FDA Warning Letter to Beta Bionics, Inc.
The FDA issued a warning letter to Beta Bionics, Inc. regarding violations of the Quality System Regulation for their iLet Dosing Decision Software and iLet ACE Pump. The letter details failures in corrective and preventive action procedures, including inadequate analysis of complaints leading to serious adverse health outcomes.
FDA Warning Letter to Diasol, Inc. for Medical Device Violations
The FDA issued a warning letter to Diasol, Inc. for manufacturing unapproved and misbranded medical devices, specifically disinfectants for hemodialysis systems. The company also violated Quality System Regulation requirements. The FDA has requested corrective actions to ensure compliance.
FDA Warning Letter to Yuyao City Boss Vegetable Factory
The FDA issued a warning letter to Yuyao City Boss Vegetable Factory Co. Ltd. for serious violations of food safety regulations, including failure to maintain processing records and fabrication of data. The violations relate to acidified foods intended for export to the United States.
FDA Warning Letter to John Yoder Farm
The FDA issued a warning letter to John Yoder Farm for serious violations of the Shell Egg Regulation (21 CFR Part 118) and the FD&C Act. The farm failed to implement a written Salmonella Enteritidis Prevention Plan and had other insanitary conditions. The FDA is concerned about the compliance status and potential health risks.
FDA Warning Letter to The Father's Table, LLC
The FDA issued a warning letter to The Father's Table, LLC, for serious violations of Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventative Controls for Human Food regulations. The inspection found Listeria monocytogenes in the facility, rendering ready-to-eat food products adulterated.
FDA Warning Letter to Black Sheep Egg Company
The FDA issued a warning letter to Black Sheep Egg Company, LLC, following an inspection that detected Salmonella in environmental samples from their shell egg processing facility. The company is cited for insanitary conditions and violations of the Shell Egg regulation, rendering their products adulterated.
FDA Warning Letter to Supercan Bully Sticks LLC
The FDA issued a warning letter to Supercan Bully Sticks LLC on September 24, 2025, following inspections that revealed serious violations of the Foreign Supplier Verification Program (FSVP) and Current Good Manufacturing Practice regulations. These violations were identified after a voluntary recall of pet treats due to Salmonella contamination.
Browse by category
US Federal
938 sources
US State
116 sources
US Courts
122 sources
UK
61 sources
EU
53 sources
Canada
23 sources
Courts & Legal
247 sources
Government & Legislation
240 sources
Banking & Finance
211 sources
Trade & Sanctions
122 sources
Healthcare
117 sources
Labor & Employment
110 sources
Energy
101 sources
Environment
82 sources
Pharma & Drug Safety
77 sources
Securities & Markets
73 sources
Agriculture & Food Safety
61 sources
Data Privacy & Cybersecurity
59 sources
Insurance
58 sources
Transportation
56 sources
Tax
54 sources
Defense & National Security
48 sources
Consumer Protection
35 sources
Telecom & Technology
34 sources
Education
20 sources
Housing
15 sources
Immigration
8 sources
Energy & Utilities
1 sources
Browse by agency
HRSA
3 sources
NSF
3 sources
CBSA
3 sources
HHS OIG
3 sources
STB
3 sources
KS Courts
3 sources
SFO
3 sources
VA
3 sources
AMF France
3 sources
FFIEC
3 sources
AL Courts
3 sources
ESMA
3 sources
FEC
3 sources
NY Courts
3 sources
VA Courts
3 sources
EU Council
3 sources
ACPR
3 sources
DOC
3 sources
EIOPA
3 sources
NTSB
3 sources
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.